Background/Aims: Aminopeptidase P (APP) is specifically enriched in caveolae on the luminal surface of pulmonary vascular endothelium. APP antibodies bind lung endothelium in vivo and are rapidly and actively pumped across the endothelium into lung tissue. Here we characterize the immunotargeting properties and pharmacokinetics of the APP-specific recombinant antibody 833c. Methods: We used in situ binding, biodistribution analysis and in vivo imaging to assess the lung targeting of 833c. Results: More than 80% of 833c bound during the first pass through isolated perfused lungs. Dynamic SPECT acquisition showed that 833c rapidly and specifically targeted the lungs in vivo, reaching maximum levels within 2 min after intravenous injection. CT-SPECT imaging revealed specific targeting of 833c to the thoracic cavity and co-localization with a lung perfusion marker, Tc99m-labeled macroaggregated albumin. Biodistribution analysis confirmed lung-specific uptake of 833c which declined by first-order kinetics (t½ = 110 h) with significant levels of 833c still present 30 days after injection. Conclusion: These data show that APP expressed in endothelial caveolae appears to be readily accessible to circulating antibody rather specifically in lung. Targeting lung-specific caveolar APP provides an extraordinarily rapid and specific means to target pulmonary vasculature and potentially deliver therapeutic agents into the lung tissue.

Keywords:
Aminopeptidase P, Biodistribution, Caveolae, CT-SPECT, Lung targeting
1.
Durr E, Yu J, Krasinska KM, Carver LA, Yates JR, Testa JE, Oh P, Schnitzer JE: Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol 2004;22:985–992.
2.
Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, Testa JE, Schnitzer JE: Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004;429:629–635.
3.
McIntosh DP, Tan XY, Oh P, Schnitzer JE: Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci USA 2002;99:1996–2001.
4.
Valadon P, Garnett JD, Testa JE, Bauerle M, Oh P, Schnitzer JE: Screening phage display libraries for organ-specific vascular immunotargeting in vivo. Proc Natl Acad Sci USA 2006;103:407–412.
5.
Oh P, Borgstrom P, Witkiewicz H, Li Y, Borgstrom BJ, Chrastina A, Iwata K, Zinn KR, Baldwin R, Testa JE, Schnitzer JE: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol 2007;25:327–337.
6.
Nordwig A, Dehm P: Breakdown of protein: cleavage of peptides of the x-pro-y type by kidney peptidases. Biochim Biophys Acta 1968;160:293–295.
7.
Hyde RJ, Hooper NM, Turner AJ: Cloning and functional expression of pig kidney aminopeptidase P. Biochem Soc Trans 1996;24:470S.
8.
Kitamura S, Carbini LA, Carretero OA, Simmons WH, Scicli AG: Potentiation by aminopeptidase P of blood pressure response to bradykinin. Br J Pharmacol 1995;114:6–7.
9.
Kitamura S, Carbini LA, Simmons WH, Scicli AG: Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses. Am J Physiol 1999;276:H1664–1671.
10.
Simmons WH, Orawski AT: Membrane-bound aminopeptidase P from bovine lung. Its purification, properties, and degradation of bradykinin. J Biol Chem 1992;267:4897–4903.
11.
Ersahin C, Simmons WH: Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation. J Cardiovasc Pharmacol 1997;30:96–101.
12.
Griswold JA, Beall CV, Baker CR Jr, Little DT, Little GH, Behal FJ: Bradykinin metabolism in the liver and lung of the rat. J Surg Res 1996;66:12–20.
13.
Essler M, Ruoslahti E: Molecular specialization of breast vasculature: a breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature. Proc Natl Acad Sci USA 2002;99:2252–2257.
14.
Valadon P, Darsow B, Buss TN, Czarny M, Griffin NM, Nguyen HN, Oh P, Chrastina A, Borgstrom P, Schnitzer JE: Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo. J Biol Chem 2009;285:713–722.
15.
Jacobson BS, Schnitzer JE, McCaffery M, Palade GE: Isolation and partial characterization of the luminal plasmalemma of microvascular endothelium from rat lungs. Eur J Cell Biol 1992;58:296–306.
16.
Oh P, Schnitzer JE: Isolation and subfractionation of plasma membranes to purify caveolae separately from glycosyl-phospatidylinositol-anchored protein microdomains; in Celis J (ed): Cell Biology: A Laboratory Handbook. Amsterdam, Academic Press, 1998, vol 2, pp 34–46.
17.
Magnet AD, Schnitzer JE: Purification of luminal endothelial membrane with plasmalemmal vesicles from tissues in situ. FASEB J 1992;6:A1033.
18.
Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, Oh P: Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 1995;269:1435–1439.
19.
Schnitzer JE, Oh P, McIntosh DP: Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science 1996;274:239–242. Erratum in 15;274:1069.
20.
Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA Jr: Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Methods 1984;72:77–89.
21.
Gottschalk A: Technetium-99m in clinical nuclear medicine. Annu Rev Med 1969;20:131–140.
22.
Danilov SM, Gavrilyuk VD, Franke FE, Pauls K, Harshaw DW, McDonald TD, Miletich DJ, Muzykantov VR: Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol 2001;280:L1335–L1347.
23.
Hendriks D, De Meester I, Umiel T, Vanhoof G, van Sande M, Scharpe S, Yaron A: Aminopeptidase P and dipeptidyl peptidase IV activity in human leukocytes and in stimulated lymphocytes. Clin Chim Acta 1991;196:87–96.
24.
Testa JE, Chrastina A, Li Y, Oh P, Schnitzer JE: Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat. J Vasc Res 2009;46:311–324.
25.
Testa JE, Chrastina A, Oh P, Li Y, Witkiewicz H, Czarny M, Buss T, Schnitzer JE: Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol 2009;297:L251–L262.
26.
Durr E, Yu J, Krasinska KM, Carver LA, Yates JRI, Testa JE, Oh P, Schnitzer JE: Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nature Biotechnol 2004;22:985–992.
27.
Schott ME, Milenic DE, Yokota T, Whitlow M, Wood JF, Fordyce WA, Cheng RC, Schlom J: Differential metabolic patterns of iodinated versus radiometal chelated anticarcinoma single-chain FV molecules. Cancer Res 1992;52:6413–6417.
28.
Govindan SV, Mattes MJ, Stein R, McBride BJ, Karacay H, Goldenberg DM, Hansen HJ, Griffiths GL: Labeling of monoclonal antibodies with diethylenetriaminepentaacetic acid-appended radioiodinated peptides containing d-amino acids. Bioconjug Chem 1999;10:231–240.
29.
Reist CJ, Archer GE, Kurpad SN, Wikstrand CJ, Vaidyanathan G, Willingham MC, Moscatello DK, Wong AJ, Bigner DD, Zalutsky MR: Tumor-specific anti-epidermal growth factor receptor variant iii monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts. Cancer Res 1995;55:4375–4382.
30.
Dhimitruka I, Bobko AA, Hadad CM, Zweier JL, Khramtsov VV: Synthesis and characterization of amino derivatives of persistent trityl radicals as dual function pH and oxygen paramagnetic probes. J Am Chem Soc 2008;130:10780–10787.
31.
Zhang L, Bhojani MS, Ross BD, Rehemtulla A: Molecular imaging of protein kinases. Cell Cycle 2008;7:314–317.
32.
Zhang L, Lee KC, Bhojani MS, Khan AP, Shilman A, Holland EC, Ross BD, Rehemtulla A: Molecular imaging of akt kinase activity. Nat Med 2007;13:1114–1119.
33.
Dolovich M, Labiris R: Imaging drug delivery and drug responses in the lung. Proc Am Thorac Soc 2004;1:329–337.
34.
Schuster DP, Kovacs A, Garbow J, Piwnica-Worms D: Recent advances in imaging the lungs of intact small animals. Am J Respir Cell Mol Biol 2004;30:129–138.
35.
Herschman HR: Molecular imaging: Looking at problems, seeing solutions. Science 2003;302:605–608.
36.
Massoud TF, Gambhir SS: Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545–580.
37.
Grimm J, Kirsch DG, Windsor SD, Kim CF, Santiago PM, Ntziachristos V, Jacks T, Weissleder R: Use of gene expression profiling to direct in vivo molecular imaging of lung cancer. Proc Natl Acad Sci USA 2005;102:14404–14409.
38.
Jones HA: Inflammation imaging. Proc Am Thorac Soc 2005;2:545–548, 513–544.
39.
Wickline SA, Lanza GM: Nanotechnology for molecular imaging and targeted therapy. Circulation 2003;107:1092–1095.
© 2010 S. Karger AG, Basel
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.